Library

feed icon rss

Your email was sent successfully. Check your inbox.

An error occurred while sending the email. Please try again.

Proceed reservation?

Export
  • 1
    Electronic Resource
    Electronic Resource
    Copenhagen : Munksgaard International Publishers
    Journal of pineal research 31 (2001), S. 0 
    ISSN: 1600-079X
    Source: Blackwell Publishing Journal Backfiles 1879-2005
    Topics: Medicine
    Notes: The in vitro incorporation of 3H-radio-labeled arachidonic (20:4n-6) and docosahexaenoic (22:6n-3) acids by the photosensitive trout pineal gland was visualized using photon and electron microscopy. After 6 hr of incubation, 3H-20:4n-6 appeared distributed in photoreceptors, as well as in glial cells, whereas 3H-22:6n-3 was preferentially taken up by photoreceptors, mainly in the apical part (including the photoreceptive outer segment). Radioactivity was mainly seen over membranes of glia when the incorporation of 3H-20:4n-6 was followed by 12–18 hr of chase. We also report differences in the incorporation of 14C-radio-labeled linoleic (18:2n-6), linolenic (18:3n-3), eicosapentenoic (20:5n-3), 20:4n-6, and 22:6n-3 acids into the lipids in glands cultured under different lighting regimes. Phosphatidylcholine and triacylglycerols contained most of the radio-labeled polyunsaturated fatty acids (PUFA) incorporated. The proportion of incorporated 20:4n-6 recovered in phosphatidylinositol was always significantly higher than that found with the other PUFA. At least 10% of radioactivity from each incorporated substrate, except 22:6n-3, was recovered in elongation products. It is concluded that the pineal gland of the trout can assimilate exogenous PUFA into cellular lipids in vitro, in a manner consistent with our previous in vivo findings. In terms of lipid composition, the trout pineal gland resembles more the vertebrate retina than the rat pineal gland. This might be related to the loss of direct photosensitivity of the mammalian pineal. Together, the differences reported herein between 22:6n-3 and 20:4n-6 suggest the former plays an important role in the phototransduction process, whereas the latter might be more specifically involved in the production of phosphoinositide-derived second messengers.
    Type of Medium: Electronic Resource
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 2
    ISSN: 1569-8041
    Keywords: cardiac toxicity ; endomyocardial biopsy scores ; liposomal doxorubicin ; MUGA scans
    Source: Springer Online Journal Archives 1860-2000
    Topics: Medicine
    Notes: Abstract Background:The indications for pegylated liposomal doxorubicin(doxil) are expanding. We, therefore, wished to assess the safety ofdelivering doses exceeding 500 mg/m2 of doxil to patients withsolid tumors. Patients and methods:Subjects accrued to eight phase I and IIprotocol studies conducted at two institutions, were assessed for cardiacfunction at baseline and at specified intervals by MUGA scans. In thisretrospective analysis, the findings of 42 patients, from the total of 237entered, who had reached or exceeded cumulative doses of 500 mg/m2(range 500–1500 mg/m2) were reviewed. Changes in leftventricular ejection fraction (LVEF), and in clinical cardiac status wereanalyzed. Six patients, three who had received prior doxorubicin, alsounderwent endomyocardial biopsies after cumulative doses of 490–1320mg/m2. Results:None of the 42 patients had clinical congestive heartfailure (CHF) secondary to cardiomyopathy. Post doxil MUGA scans wereavailable for 41 of the 42 patients. Five had a drop of 10% or more inLVEF; three of these had received prior doxorubicin. Billingham endomyocardialbiopsy scores ranged from 0–1 in five patients, while the sixth had ascore of 1.5 after both 900 mg/m2 and 1320 mg/m2 doxil.Of a remaining 195 patients, 1 episode of CHF was recorded in a patient whohad received 312 mg/m2 doxil over 120 mg/m2 ofmitoxantrone and chest radiation. Conclusions:Cumulative doses in excess of 500 mg/m2of doxil appear to carry a considerably lesser risk of cardiomyopathy asjudged by serial LVEF's and clinical follow-up, than is generally associatedwith free doxorubicin. Heart biopsies have provided reassuring data in a smallnumber of patients, even if pretreated with doxorubicin. However, since threedoxorubicin pretreated patients were among the five experiencing drops inLVEF, more data are warranted on such patients.
    Type of Medium: Electronic Resource
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
Close ⊗
This website uses cookies and the analysis tool Matomo. More information can be found here...